

NCT02886962 comparison:

Summary:
CHIA has 18 criteria while your personal folder has 18 criteria
Total found criteria: 18/18
Total not Found: 0/18
Total Extra: 1
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Adult patients (= 18 years)                        │ Adult patients (≥ 18 years)                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient on hemodialysis treatment for at least 1   │ Patient on hemodialysis treatment for at least 1   │
│ month                                              │ month                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient with a history of, or presenting a new     │ Patient with a history of, or presenting a new     │
│ episode of atrial fibrillation (either permanent   │ episode of atrial fibrillation (either permanent   │
│ or paroxysmal)                                     │ or paroxysmal)                                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient with a CHADS2VASC score =2                 │ Patient with a CHADS2VASC score ≥2                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient with high risk of bleeding as defined by   │ Patient with high risk of bleeding as defined by   │
│ (1) HASBLED score =3 OR (2) HASBLED = CHADS2VASC   │ (1) HASBLED score ≥3 OR (2) HASBLED ≥ CHADS2VASC   │
│ score, OR (3) recent history of severe bleeding    │ score, OR (3) recent history of severe bleeding    │
│ (type 3a, 3b, 3c), particularly cerebral or        │ (type 3a, 3b, 3c), particularly cerebral or        │
│ gastrointestinal, OR (4) prior recurrent (>2)      │ gastrointestinal, OR (4) prior recurrent (\>2)     │
│ history of falls                                   │ history of falls                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient capable of understanding information about │ Patient capable of understanding information about │
│ the study and of giving his/her consent            │ the study and of giving his/her consent            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient informed of the preliminary medical exam   │ Patient informed of the preliminary medical exam   │
│ results                                            │ results                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient with healthcare insurance                  │ Patient with healthcare insurance                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Written consent signed                             │ Written consent signed                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Formal indication to oral anticoagulation beside   │ Formal indication to oral anticoagulation beside   │
│ atrial fibrillation (mechanic heart valves,        │ atrial fibrillation (mechanic heart valves,        │
│ recurrent thrombophlebitis, antiphospholipid       │ recurrent thrombophlebitis, antiphospholipid       │
│ syndrome)                                          │ syndrome)                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Life expectancy < 6 months (e.g., terminal cancer) │ Life expectancy \< 6 months (e.g., terminal        │
│                                                    │ cancer)                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Live donor transplantation scheduled within 6      │ Live donor transplantation scheduled within 6      │
│ months                                             │ months                                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnancy (ß-HCG blood-based assay)or nursing      │ Pregnancy (β-HCG blood-based assay)or nursing      │
│ (lactating) women                                  │ (lactating) women                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Women of child bearing potential, unless they are  │ Women of child bearing potential, unless they are  │
│ using an effective method of birth control         │ using an effective method of birth control         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient under legal guardianship                   │ Patient under legal guardianship                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients under law protection                      │ Patients under law protection                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known hypersensibility to coumadin or indoine      │ Known hypersensibility to coumadin or indoine      │
│ derivatives or to any excipients (CI to oral AVK)  │ derivatives or to any excipients (CI to oral AVK)  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Severe liver failure (CI to oral AVK)              │ Severe liver failure (CI to oral AVK)              │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 18 Years │
╘═══════════════════════════════════╛